169 related articles for article (PubMed ID: 33136952)
1. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Zhang D; Earp BE; Benavent KA; Blazar P
Plast Reconstr Surg; 2020 Nov; 146(5):1071-1079. PubMed ID: 33136952
[TBL] [Abstract][Full Text] [Related]
2. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
Holzer LA; Holzer G
Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
[TBL] [Abstract][Full Text] [Related]
3. Long-term Effects of Skin Tearing on Outcomes After Collagenase Treatment of Dupuytren Contractures.
Zhang D; Blazar P; Benavent KA; Earp BE
Hand (N Y); 2021 Nov; 16(6):792-796. PubMed ID: 31941375
[No Abstract] [Full Text] [Related]
4. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum].
Martín-Ferrero MÁ; Simón-Pérez C; Rodríguez-Mateos JI; García-Medrano B; Hernández-Ramajo R; Brotat-García M
Rev Esp Cir Ortop Traumatol; 2013; 57(6):398-402. PubMed ID: 24071041
[TBL] [Abstract][Full Text] [Related]
6. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
[TBL] [Abstract][Full Text] [Related]
8. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
9. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
[TBL] [Abstract][Full Text] [Related]
11. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
[TBL] [Abstract][Full Text] [Related]
12. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
Abe Y
Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
[TBL] [Abstract][Full Text] [Related]
14. A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2 year follow-up of 47 patients.
McFarlane J; Syed AM; Sibly TF
J Hand Surg Eur Vol; 2016 Jul; 41(6):664-5. PubMed ID: 26269508
[No Abstract] [Full Text] [Related]
15. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
Sefton AK; Smith BJ; Stewart DA
J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
17. Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
Sanjuan-Cervero R; Carrera-Hueso FJ; Oliver-Mengual S; Ramon-Barrios MA; Peimer CA; Fikri-Benbrahim N
Orthop Nurs; 2018; 37(2):144-153. PubMed ID: 29570549
[TBL] [Abstract][Full Text] [Related]
18. Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren's disease in 788 patients: the Austrian register.
Rohit A; Peter A; Paul A; Anja B; Christian D; Renate D; Stefan G; Dietmar H; Johannes J; Peter K; Marco K; Martin L; Maximilian N; Christoph P; Gernot S; Gerald S; Tobias S; Matthias W; Armin Z; Markus G
Arch Orthop Trauma Surg; 2019 Sep; 139(9):1315-1321. PubMed ID: 31317303
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing recurrence and progression of Dupuytren's disease treated by Collagenase Clostridium histolitycum.
Simón-Pérez C; Alía-Ortega J; García-Medrano B; Rodríguez-Mateos JI; Brotat-Rodríguez M; Aguado-Hernandez H; Martín-Ferrero MA
Int Orthop; 2018 Apr; 42(4):859-866. PubMed ID: 29170879
[TBL] [Abstract][Full Text] [Related]
20. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Smeraglia F; Del Buono A; Maffulli N
Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
